We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+1.78%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$253B
AUM Growth
+$4.08B
Cap. Flow
+$937M
Cap. Flow %
0.37%
Top 10 Hldgs %
19.37%
Holding
7,530
New
489
Increased
3,007
Reduced
2,579
Closed
641

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$309M
2
ENB icon
Enbridge
ENB
+$233M
3
T icon
AT&T
T
+$219M
4
AGN
Allergan plc
AGN
+$211M
5
MET icon
MetLife
MET
+$202M

Sector Composition

Rank Sector Weight
1 Financials 21.04%
2 Technology 8.79%
3 Energy 8.22%
4 Industrials 7.49%
5 Communication Services 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISEE
6051
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4K ﹤0.01%
3,438
+733
+27% +$853
VYNT
6052
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$4K ﹤0.01%
233
+73
+46% +$1.42K
RUBY
6053
DELISTED
Rubius Therapeutics, Inc
RUBY
$4K ﹤0.01%
+555
New +$6.47K
CEA
6054
DELISTED
China Eastern Airlines
CEA
$4K ﹤0.01%
180
-30
-14% -$785
STAB
6055
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$4K ﹤0.01%
3,624
-3
-0.1% -$4
ICOL
6056
DELISTED
iShares MSCI Colombia ETF
ICOL
$4K ﹤0.01%
350
HNP
6057
DELISTED
Huaneng Power Intl, Inc.
HNP
$4K ﹤0.01%
212
+12
+6% +$270
PTE
6058
DELISTED
PolarityTE, Inc. Common Stock
PTE
$4K ﹤0.01%
46
+12
+35% +$1.37K
QTS.PRB
6059
DELISTED
QTS Realty Trust, Inc. 6.50% Series B Cumulative Convertible Perpetual Preferred Stock
QTS.PRB
0
OXFD
6060
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$4K ﹤0.01%
245
RST
6061
DELISTED
ROSETTA STONE INC
RST
$4K ﹤0.01%
223
-4
-2% -$81
FSCT
6062
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$4K ﹤0.01%
+116
New +$4.24K
JPMV
6063
DELISTED
iShares Edge MSCI Min Vol Japan ETF
JPMV
$4K ﹤0.01%
+55
New +$3.61K
CHK
6064
PUT
DELISTED
Chesapeake Energy Corporation
CHK
$4K ﹤0.01%
13
-12
-48% -$3.9K
PGNX
6065
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$4K ﹤0.01%
944
+500
+113% +$2.49K
LBY
6066
DELISTED
Libbey, Inc.
LBY
$4K ﹤0.01%
1,126
+788
+233% +$1.54K
JMEI
6067
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$4K ﹤0.01%
200
TYPE
6068
DELISTED
Monotype Imaging Holdings Inc.
TYPE
$4K ﹤0.01%
+219
New +$4.17K
CDOR
6069
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$4K ﹤0.01%
380
+361
+1,900% +$3.79K
OHAI
6070
DELISTED
OHA Investment Corporation
OHAI
$4K ﹤0.01%
3,225
-25
-0.8% -$31
JHMA
6071
DELISTED
John Hancock Multifactor Materials ETF
JHMA
$4K ﹤0.01%
134
MCF
6072
DELISTED
Contango Oil & Gas Co.
MCF
$4K ﹤0.01%
1,343
+308
+30% +$430
BAS
6073
DELISTED
Basis Energy Services, Inc.
BAS
$4K ﹤0.01%
2,678
+1,435
+115% +$2.41K
ADAP
6074
DELISTED
Adaptimmune Therapeutics
ADAP
$3K ﹤0.01%
2,000
ALLY icon
6075
PUT
Ally Financial
ALLY
$13.6B
$3K ﹤0.01%
+100
New +$3.24K

Similar funds

Royal Bank of Canada's Q3 2019 Portfolio in Review

As of Q3 2019, Royal Bank of Canada held 7,530 positions worth $253B, up 1.6% from $249B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q3 2019 filing shows 489 new, 3,007 increased, 2,579 reduced and 641 closed positions. Its largest new stake was Genmab: 424,217 shares worth $8.6M. The largest sale was iShares Core S&P 500 ETF, an estimated $983M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Energy.

  • Royal Bank of Canada's largest Q3 2019 buy was Genmab: 424,217 shares worth $8.6M.
  • Royal Bank of Canada added most to Boeing in Q3 2019, an estimated $309M increase.
  • Royal Bank of Canada's biggest Q3 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
  • Royal Bank of Canada fully exited Anadarko Petroleum in Q3 2019, selling an estimated $83.7M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $253B portfolio in Q3 2019.
  • Royal Bank of Canada opened 489 new positions and closed 641 in Q3 2019.
  • Royal Bank of Canada's portfolio value rose 1.6% quarter-over-quarter to $253B.

Based on Royal Bank of Canada's 13F filing for Q3 2019, filed 14 Nov 2019.